Posted inMarket Definium Therapeutics CEO Robert Barrow Sells Over $721K in Company Shares Definium Therapeutics CEO Robert Barrow recently executed a stock sale totaling $721,732. Learn the details of this executive transaction. Posted by Prasenjit Bhowmik October 16, 2026